|
|
Research in Pharmaceutical Sciences، جلد ۲۰، شماره ۱، صفحات ۰-۰
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
A novel hybrid approach to overcome defects of CE-SELEX and cell-SELEX in developing aptamers against aspartate β-hydroxylase |
|
| چکیده انگلیسی مقاله |
Background and purpose: Aptamers, a new category of molecular probes, are overthrowing antibodies in molecular diagnostics. However, there are serious problems with using aptamers for this application including poor or non-specific binding in vivo conditions. Systematic evolution of aptamers is achieved through various approaches including CE-SELEX and Cell-SELEX, each suffering its inevitable weaknesses. The shortcomings of negative selection and the lengthy procedure are Cell-SELEX's main problems, while CE-SELEX is deprived of native targets. Here, we introduced a kind of hybrid CE-Cell-SELEX, named CEC hybrid-SELEX, for addressing these limitations in creating aptamer probes detecting human aspartate β-hydroxylase (ASPH), which is a well-established tumor biomarker, in cancer diagnostic investigations. Experimental approach: In our approach, the selected oligomer pool from the last cycle of CE-SELEX was sequenced and then subjected to 3 additional rounds of Cell-SELEX which provides native ASPH (CEC hybrid-SELEX). High-throughput sequencing was applied to achieve a comprehensive sight of the enriched pools. Further confirmatory investigations on oligomers with higher copy numbers were performed using flow cytometry. Findings/Results: Three selected oligomers, AP-CEC 1, AP-CEC 2, and AP-CEC 3, showing Kd values of 43.09 nM, 34.85 nM, and 35.92 nM, respectively, were achieved based on the affinity assessment of the ASPH-expressing cells. Conclusion and implications: Our research suggested that CEC hybrid-SELEX could help recognize which oligomers from CE-SELEX are more capable of binding native ASPH in vivo . |
|
| کلیدواژه‌های انگلیسی مقاله |
Aptamers,Aspartate β-hydroxylase,Capillary electrophoresis,High-throughput nucleotide sequencing,SELEX aptamer technique. |
|
| نویسندگان مقاله |
| Hadi Bakhtiari
Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran.
| Hamed Naghoosi
Health Research Center, Shahid Chamran Hospital, Tehran, Iran.
| Sina Sattari
Medical Biotechnology Research Center, Aja University of Medical Sciences, Tehran, Iran.
| Mahmoud Vahidi
Medical Biotechnology Research Center, Aja University of Medical Sciences, Tehran, Iran.
| Mehdi Shakouri Khomartash
Cancer Epidemiology Research Center (AJA-CERTC), Aja University of Medical Sciences, Tehran, Iran.
| Ali Faridfar
Cancer Epidemiology Research Center (AJA-CERTC), Aja University of Medical Sciences, Tehran, Iran.
| Mohsen Rajaeinejad
Cancer Epidemiology Research Center (AJA-CERTC), Aja University of Medical Sciences, Tehran, Iran.
| Mohsen Nikandish
|
|
| نشانی اینترنتی |
http://rps.mui.ac.ir/index.php/jrps/article/view/2293 |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
Original Article |
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|